@article{96632adf250b4211bc41e77de7ef5ee9,
title = "Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience",
abstract = "na",
keywords = "B-Cell receptor, chronic lymphocytic leukaemia, ibrutinib, idelalisib, venetoclax, B-Cell receptor, chronic lymphocytic leukaemia, ibrutinib, idelalisib, venetoclax",
author = "Idanna Innocenti and Francesca Morelli and Francesco Autore and Alfonso Piciocchi and Annamaria Frustaci and Mauro, \{Francesca R.\} and Luana Schiattone and Livio Trentin and \{Del Poeta\}, Giovanni and Gianluigi Reda and Rigolin, \{Gian M.\} and Adalberto Ibatici and Stefania Ciolli and Marta Coscia and Paolo Sportoletti and Roberta Murru and Luciano Levato and Massimo Gentile and Giovanni D'Arena and Efremov, \{Dimitar G.\} and Alessandra Tedeschi and Lydia Scarf{\`o} and Antonio Cuneo and Robin Fo{\`a} and Luca Laurenti",
year = "2019",
doi = "10.1111/bjh.16123",
language = "English",
volume = "187",
pages = "e8--e11",
journal = "British Journal of Haematology",
issn = "1365-2141",
publisher = "John Wiley and Sons Inc.",
}